“Systemic racism is as real as any disease,” says Rebecca Marklund in a recent PhRMA blog. “Diversifying clinical trials is a critical path to change and PhRMA, and its members, […]
For decades, the power of the placebo effect was thought to lie in patients’ belief that they were—or at least, could be—receiving a pharmacologically active treatment. A new study by […]
The COVID-19 pandemic proved the clinical trial industry can rally quickly to develop vaccines in record time. It also may have proven that remote monitoring of study sites is here […]
Even with access to a clinical trial, cancer patients living in the poorest neighborhoods in America have a nearly 30% greater chance of dying from their disease compared to the […]
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to […]